CHD

Business profile & competitive position

Church & Dwight Co., Inc. operates squarely in the Consumer Defensive sector, specifically the Household & Personal Products industry. The company develops, manufactures and markets consumer household and personal-care brands, and it also runs a Specialty Products Division covering animal nutrition, specialty chemicals and commercial/professional cleaners. Its brand list reads like an aisle tour: ARM & HAMMER, OXICLEAN, BATISTE, WATERPIK, THERABREATH, HERO, TOUCHLAND, TROJAN, FIRST RESPONSE, NAIR, ORAJEL, XTRA and ZICAM. Operations are organized into three segments: Consumer Domestic, Consumer International and Specialty Products Division.

The financial footprint hints at solid but not extraordinary competitive strength. The trailing net margin is 12.0%, which is respectable for a staples portfolio but not a wide-moat margin by household-products standards. The 17.8% ROE points to efficient capital generation. Combined with a 0.48 beta, the numbers reflect a stable, brand-driven business rather than a high-growth disruptor: recurring demand, modest leverage to economic cycles, and the ability to earn returns comfortably above its cost of capital. Yet the modest margin also means pricing power and cost control matter; CHD is not so profitable that it can absorb sustained commodity or freight shocks without working capital discipline.

Financial posture

As of the latest data, Church & Dwight carried a market capitalization of $24.8 billion and traded at a P/E ratio of 33.5. That multiple is on the richer side for a consumer-staples name, implying investors are paying a premium for stability and perceived earnings reliability. The 12.0% net margin and 17.8% ROE back up the quality narrative, while the very low 0.48 beta underscores why the stock is often grouped with “flight-to-safety” consumer-defensive names: when broad equity volatility rises, CHD tends to move less than half as much as the overall market. The current snapshot shows the stock at $104.53 with a 50-day EMA of $98.00 and an RSI of 77.6, indicating that the price has run well above its short-term average.

The valuation context matters for any post-earnings read. A 33.5x multiple means good news is often priced in before it arrives, and even modest disappointment can trigger compression. Low-beta status keeps drawdowns milder than the market in absolute terms, but it does not eliminate the risk that expectations have outpaced fundamentals.

Strategic priorities & outlook

The company’s most recent 10-K filing outlines a clear near-term agenda. Church & Dwight is repositioning the portfolio toward faster-growing value and premium product lines, a shift accelerated by exits including Flawless, Spinbrush, Waterpik showerhead and the VMS brands. Management is integrating the Touchland hand-sanitizer acquisition and expects that deal to contribute meaningfully to sales and earnings as it scales.

Another pillar is global expansion of the seven “power brands.” These seven brands represented approximately 70% of consolidated net sales and profits in 2025, so their trajectory effectively is the company’s trajectory. The filing also notes that the Consumer Domestic segment in 2025 was split roughly 54% household products and 46% personal care. On the operational side, CHD has been building supply-chain resilience by maintaining qualified dual sources for roughly 70% of direct materials spend. A notable customer concentration risk is impossible to miss: Walmart accounted for about 23% of consolidated net sales in 2025, and no other customer exceeded 10% over the past three years. That concentration is normal in U.S. retailing but remains a structural vulnerability if merchandising terms, shelf space or pricing power shift.

Macro & geopolitical exposure

Because CHD is classified in Household & Personal Products, its macro exposures are those typical of global consumer staples: input commodities and packaging materials, freight and logistics costs, currency translation for international operations, and regulatory oversight. Plastics, surfactants, paper, chemicals and propellants can all move with oil and industrial-commodity prices, while ocean and trucking rates affect margin recovery timelines. International revenue adds dollar-strength sensitivity, especially in the Consumer International segment and the global push behind the power brands.

Regulation is another constant. Products spanning oral care, feminine care, pregnancy diagnostics, condoms and specialty chemicals sit under FDA, FTC and EPA scrutiny in the U.S. and similar agencies abroad. Trade policy also matters: tariffs on Chinese sourced components or packaging, as well as any retaliatory duties on U.S. exports, can pressure both cost of goods and international growth. The good news is that staples demand is relatively inelastic, so revenue volatility tends to be lower than in discretionary sectors; the bad news is that margin volatility from the above factors is real.

Recent developments

Headlines over the past week have positioned Church & Dwight as a defensive refuge. On 2026-10-16, 247wallst.com published “The Stocks That Will Get Investors Home Safe When Tech Cracks,” framing CHD as a shelter name amid technology-sector weakness. On 2026-10-15, defenseworld.net reported that Krilogy Financial LLC acquired 41,582 shares of Church & Dwight. That same theme carried into fool.com on 2026-10-13 with “Why I Just Invested in This Dividend King -- Even Though a Smaller Rival Has Grown Faster,” and again on 2026-10-12 with “My Top Dividend Growth Stock to Buy in October and Hold Forever.”

Collectively, the coverage highlights income-oriented and low-volatility appeal, though the repeated “dividend king” framing also raises the possibility that safe-haven demand has already pushed the stock toward technically stretched levels. The RSI reading of 77.6 and the gap above the 50-day EMA of $98.00 both occurred alongside that defensive narrative.

Earnings behavior & post-earnings drift

Church & Dwight’s recent earnings record is strong by headline standards: over the last eight reported quarters it beat estimates six times, for a 75% beat rate, and the average earnings surprise was +5.2%. The average 5-day price move in the sessions after earnings was +1.32%, classified as an upward drift. The next report is scheduled for 2026-10-30 before the open, with a consensus EPS estimate of $0.899.

But averages hide an important nuance. CHD’s post-earnings reaction has not reliably followed the direction of the surprise. In the most recent four quarters, the one miss—2026-07-31, when actual EPS of $0.89 missed the $0.896 estimate by 0.7%—was followed by a +1.21% next-day move and a +4.48% gain over the next five days. Meanwhile, several beats were sold. On 2026-05-01, CHD beat by 2%, reporting $0.95 against the $0.931 estimate, yet the stock fell 3.26% the next day and 2.69% over the next five sessions. The largest beat in the quartet, 2025-10-31’s 10.1% surprise ($0.81 vs. $0.736), produced a 1.61% drop the next day and a 0.95% five-day decline. Even the cleaner responses came with modest beats: 2026-01-30’s 2.9% beat ($0.86 vs. $0.836) led to a 1.13% next-day pop and a 4.45% five-day gain.

That pattern suggests the market’s real expectation may be tighter than the published consensus. In a 33.5x P/E stock, simply clearing estimates is sometimes not enough; investors appear to reset positions around guidance, margins and the quality of the beat. Traders looking for a mechanical “beat equals pop” edge in CHD have been disappointed more often than the headline beat rate implies. For the 2026-10-30 report, the unofficial consensus has effectively tightened the bar even if the published number is $0.899; the stock’s recent run to $104.53 and extreme RSI only raises the stakes around that report.

For a deeper dive into how institutional analysts view the stock ahead of the 2026-10-30 earnings report—including rating distributions, estimate revisions and implied volatility positioning—explore the full institutional verdict on the platform.